Kulasingam S - Search Results

1

Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.

Havrilesky LJ, Sanders GD, Kulasingam S, Chino JP, Berchuck A, Marks JR, Myers ER. Havrilesky LJ, et al. Among authors: kulasingam s. Cancer. 2011 Feb 1;117(3):545-53. doi: 10.1002/cncr.25624. Epub 2010 Dec 13. Cancer. 2011. PMID: 21254049 Free article.

2

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

Kulasingam SL, Myers ER. Kulasingam SL, et al. JAMA. 2003 Aug 13;290(6):781-9. doi: 10.1001/jama.290.6.781. JAMA. 2003. PMID: 12915431

3

Risk of cervical cancer associated with extending the interval between cervical-cancer screenings.

Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Sawaya GF, et al. N Engl J Med. 2003 Oct 16;349(16):1501-9. doi: 10.1056/NEJMoa035419. N Engl J Med. 2003. PMID: 14561792 Free article.

4

FDG-PET for management of cervical and ovarian cancer.

Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. Havrilesky LJ, et al. Gynecol Oncol. 2005 Apr;97(1):183-91. doi: 10.1016/j.ygyno.2004.12.007. Gynecol Oncol. 2005. PMID: 15790456

5

Dissemination of Evidence-based Practice Center reports.

Matchar DB, Westermann-Clark EV, McCrory DC, Patwardhan M, Samsa G, Kulasingam S, Myers E, Sarria-Santamera A, Lee A, Gray R, Liu K; Agency for Healthcare Research and Quality. Matchar DB, et al. Among authors: kulasingam s. Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1120-5. doi: 10.7326/0003-4819-142-12_part_2-200506211-00012. Ann Intern Med. 2005. PMID: 15968037 Free article. Review.

6

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ; ALTS Group. Kulasingam SL, et al. J Natl Cancer Inst. 2006 Jan 18;98(2):92-100. doi: 10.1093/jnci/djj009. J Natl Cancer Inst. 2006. PMID: 16418511

7

Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.

Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Kulasingam SL, et al. Obstet Gynecol. 2006 Feb;107(2 Pt 1):321-8. doi: 10.1097/01.AOG.0000196500.50044.ce. Obstet Gynecol. 2006. PMID: 16449119

8

Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.

Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Chernofsky M, Myers ER. Bidus MA, et al. Among authors: kulasingam s. Obstet Gynecol. 2006 May;107(5):997-1005. doi: 10.1097/01.AOG.0000210529.70226.0a. Obstet Gynecol. 2006. PMID: 16648402

9

Genomic tests for ovarian cancer detection and management.

Myers ER, Havrilesky LJ, Kulasingam SL, Sanders GD, Cline KE, Gray RN, Berchuck A, McCrory DC. Myers ER, et al. Evid Rep Technol Assess (Full Rep). 2006 Oct;(145):1-100. Evid Rep Technol Assess (Full Rep). 2006. PMID: 17764207 Free PMC article. Review.

10

Management of adnexal mass.

Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, Gray RN, McCrory DC. Myers ER, et al. Among authors: kulasingam sl. Evid Rep Technol Assess (Full Rep). 2006 Feb;(130):1-145. Evid Rep Technol Assess (Full Rep). 2006. PMID: 17854238 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters